Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review

This study evaluated the clastogenic and/or aneugenic potential of three nucleoside reverse transcriptase inhibitors (zidovudine - AZT, lamivudine - 3TC and stavudine - d4T) using

While PAHO recognizes the value of antiretroviral therapy (ARV) in the management of HIV infection and in the prevention of perinatal transmission of HIV, Member States need to view

The protease inhibitors indinavir and ritonavir have shown in vitro and in vivo inhibitory effects against Candida albicans.. 11 Indinavir also has shown activity against the

M.; CARNÉ, X.; Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase

In this study, we compared the clinical efficacy, antiretroviral activity and safety of indinavir to zidovudine or the combination of indinavir plus zidovudine in HIV-1

In the former group 8 of 12 children presented isolates with mutations conferring resistance to protease inhibitors (PIs), 7 presented isolates resistant to nucleoside

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse tran- scriptase in recombinant human immunodeficiency virus type 1 isolates

In all, there are six categories: nucleo- side reverse transcriptase inhibitors (NRTIs: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir,